- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02052570
School Reintegration After Pediatric Hematopoietic Stem Cell Transplant
February 2, 2015 updated by: Duke University
School Reintegration After Pediatric Hematopoietic Stem Cell Transplant: Experiences of Children, Parents, Teachers and Providers
This is a qualitative study that will explore the experiences of school reentry following Hematopoietic Stem Cell Transplant (HSCT) in children ages 10-16 years of age, their parents, teachers and primary PBMT(Pediatric Bone Marrow Transplant) providers.
This study will involve four focus groups: children post -transplant, parents, teachers and PBMT providers in an effort to understand the successes and challenges of returning to school following HSCT.
Study Overview
Status
Withdrawn
Detailed Description
This is a qualitative descriptive study using purposive sampling to form the four focus groups to encourage diversity in diagnosis (immunodeficiency, malignancy, bone marrow failure and inherited metabolic diseases), age and location.
Each group will participate via conference call due to difference in location.
There will be semi-structured questions for each group but also allow flexibility by participants themselves.
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke University Health Systems
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 16 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Children transplanted in the PBMT (Pediatric Bone Marrow Transplant) program at DUMC (Duke University Medical Center) in the past 5 years for allogeneic HSCT to include diagnoses for malignancy, immunodeficiency, bone marrow failure and inherited metabolic disease.
They must have previously attended school prior to transplant.
Description
Inclusion Criteria:
- Children transplanted in the PBMT program at DUMC in the past 5 years for allogeneic HSCT to include diagnoses for malignancy, immunodeficiency, bone marrow failure and inherited metabolic disease. They must have previously attended school prior to transplant
Exclusion Criteria:
- Autologous transplants
- Significant developmental delays that would impair ability to communicate
- Inability to get full team (child, parent, teacher, provider) to participate
- Non-English speaking
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Children post-HSCT
Children post-HSCT age 10-16 yrs of age who had allogeneic transplant who are within 5 years of transplant and returned to school in past 12-24 months after previously attending school pre-transplant
|
|
Parents of children post-HSCT
Parents of children post-HSCT (children in focus group) will participate in focus group with other parents to discuss the challenges and successes of their child returning to school following HSCT.
|
|
Teachers of children post-HSCT
Teachers of children post- HSCT (children in focus group) will participate in focus group with other teachers to discuss the challenges and successes of children returning to school post HSCT
|
|
PBMT provider of child post-HSCT
PBMT provider of child-post HSCT (child in focus group) will participate in in focus group with other PBMT providers to discuss the successes and challenges of coordinating school reentry in child post-HSCT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychosocial issues
Time Frame: 90 minutes
|
Psychosocial issues related to school reentry following pediatric hematopoietic stem cell transplant (HSCT) as gathered from children's, parent's, teacher's and health care provider's perspectives as obtained during focus group discussions.
|
90 minutes
|
|
Cultural and environmental issues
Time Frame: 90 minutes
|
Cultural and environmental issues (ie location, resources) issues related to school reentry following pediatric hematopoietic stem cell transplant (HSCT) gathered from the children's, parent's, teacher's and health care provider's perspectives as obtained during focus group discussions.
|
90 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Susan J Wood, MN, DUMC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Actual)
February 1, 2015
Study Completion (Actual)
February 1, 2015
Study Registration Dates
First Submitted
January 27, 2014
First Submitted That Met QC Criteria
January 30, 2014
First Posted (Estimate)
February 3, 2014
Study Record Updates
Last Update Posted (Estimate)
February 4, 2015
Last Update Submitted That Met QC Criteria
February 2, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Pro00047417
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Unspecified Complication of Bone Marrow Transplant
-
Medical College of WisconsinCompletedCancer | Effects of Chemotherapy | Unspecified Complication of Bone Marrow Transplant | Auto Immune DiseaseUnited States
-
Instituto de Investigacion Sanitaria La FeCompletedUnspecified Complication of Liver TransplantSpain
-
The University of Texas Medical Branch, GalvestonCompletedUnspecified Complication of Lung TransplantUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedSurvivors of Bone Marrow Transplant | Autologous and AllogeneicUnited States
-
Northwestern UniversityCompletedDisorder Related to Renal Transplantation | Unspecified Complication of Kidney TransplantUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Duke UniversityCompletedBone Marrow Transplant
-
Massachusetts General HospitalCompletedComplication of TransplantUnited States
-
Arizona State UniversityMayo ClinicCompleted
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedBone Marrow TransplantUnited States
-
University of Colorado, DenverGlaxoSmithKlineRecruitingStem Cell Transplant | Bone Marrow TransplantUnited States